Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a non-surgical device to reduce facial wrinkles. It targets people with facial wrinkles and works by using energy to boost skin proteins for smoother skin.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Histological examination
Secondary study objectives
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Subject Satisfaction
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for non-invasive facial rejuvenation.
Group II: ControlActive Control1 Intervention
One subject will serve as a control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2022
N/A
~160
Find a Location
Who is running the clinical trial?
BTL Industries Ltd.Lead Sponsor
53 Previous Clinical Trials
1,861 Total Patients Enrolled
13 Trials studying Wrinkles
400 Patients Enrolled for Wrinkles
Share this study with friends
Copy Link
Messenger